Avio Smart Market Stack Limited has initiated strategic discussions with Medici Institute of Medical Sciences (MIMS), Hyderabad, to explore opportunities for research collaboration, clinical validation, and adoption of advanced molecular diagnostic technologies. The engagement aims to strengthen disease detection, improve clinical decision-making, and enhance healthcare outcomes across India. This move is part of bartronics 's strategy to build a scalable Diagnostics & Healthcare business through its strategic partnership with Huwel Lifesciences.

Huwel Lifesciences, ASMS' strategic molecular diagnostics partner, showcased its portfolio of indigenous diagnostic technologies during the discussions. The portfolio includes solutions for tuberculosis, multidrug-resistant tuberculosis (MDR-TB), sepsis, HPV screening, hepatitis, antimicrobial resistance (AMR) detection, respiratory diseases, and environmental surveillance. The company highlighted its fully integrated diagnostics platform, which spans assay development, reagent manufacturing, instrumentation, software, and data management.

The discussions focused on collaborative research, clinical validation studies, real-world evidence generation, and opportunities for the adoption and deployment of Huwel's diagnostic technologies within Medici's healthcare ecosystem. The organizations also explored the possibility of pilot programs and product evaluations across selected departments to assess their impact on routine diagnostic workflows.

Strategic Objectives

Mr. Vidyasagar Reddy, Managing Director, Avio Smart Market Stack, stated that the company has made a significant commitment to building a scalable Diagnostics & Healthcare business through its partnership with Huwel Lifesciences. He emphasized that while scientific validation is important, the objective is equally focused on accelerating real-world adoption of these technologies by leading healthcare institutions. The engagement with Medici creates opportunities for research collaboration, clinical evaluation, and potential deployment of Huwel's diagnostic solutions.

Dr. Shesheer Kumar, Founder and Director, Huwel Lifesciences, noted that the future of healthcare innovation depends on close collaboration between technology developers, clinicians, and research institutions. He expressed that Medici's strong research capabilities and clinical expertise make it an ideal partner for advancing scientific validation and evaluating the impact of innovative diagnostics in real-world healthcare settings.

Key Diagnostic Areas

ASMS is actively building market access channels for advanced diagnostic technologies through partnerships with healthcare institutions, government programs, research organizations, and industry stakeholders. The company is working to accelerate validation, adoption, procurement, and large-scale deployment of indigenous diagnostic solutions across India and international markets.

Avio Smart Market Stack Limited reported a net profit of ₹5.94 crore for the financial year ended March 31, 2026, marking a 240% increase from ₹1.75 crore in the previous year. Revenue from operations for FY26 surged to ₹103.96 crore, compared to ₹40.04 crore in FY25, representing a year-on-year growth of approximately 160%. The company achieved a positive net worth during FY26, marking a significant milestone in its transformation journey and strengthening of its financial position.

The strong performance was driven by the continued expansion of the company's operating platforms, diversification across key business verticals, strengthening ecosystem partnerships and focused execution of its long-term growth strategy. For the quarter ended March 31, 2026, the company posted a net profit of ₹2.09 crore, while revenue from operations stood at ₹34.39 crore. The statutory auditors, M/s. SVRL & Co., Chartered Accountants, issued an unmodified opinion on the annual audited financial results.

Financial Performance

The company's total income for FY26 rose to ₹104.83 crore from ₹40.73 crore in the prior year. Total expenses for the period were ₹99.38 crore, up from ₹40.39 crore in FY25. The basic earnings per share (EPS) for FY26 increased to ₹0.20 from ₹0.06 in the previous year.

Segment Performance

The company operates across three verticals: Financial Inclusion & Digital Services, Agri Supply Chain & Technologies, and Diagnostics & Healthcare. The Agri Supply Chain & Technologies segment reported the highest revenue for FY26 at ₹60.69 crore, while the Financial Inclusion & Digital Services segment contributed ₹40.72 crore. The Diagnostics & Healthcare segment did not report any revenue during the year. The company continued to strengthen its Diagnostics & Healthcare business through strategic investments and ecosystem partnerships, including its association with Huwel Lifesciences.